Concepedia

K. Wilner

KW

Statistics

Publications

14

Citations

513

H-Index

12

Active since

1995

Affiliations

Pfizer (United States)(Current)

University of Colorado Denver

Seoul National University Hospital

The Ohio State University

K. Wilner is an author at Pfizer (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1995–2016

14

Publications

14

Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations

S P Myrand, Kanako Sekiguchi, MZ Man et al. · Clinical Pharmacology & Therapeutics · 2008 · 225 citations

, , +17

The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

Gregory T. Everson, Kenneth C. Lasseter, Karl E. Anderson et al. · British Journal of Clinical Pharmacology · 2000 · 46 citations · Full text

, , +17

Quantitative liver function tests define the functional severity of liver disease in early-stage cirrhosis

Rishab Shrestha, C McKinley, Radene Showalter et al. · Liver Transplantation and Surgery · 1997 · 41 citations · Full text

, , +17

The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

FT Aweeka, D. Jayesekara, Michael W. Horton et al. · British Journal of Clinical Pharmacology · 2000 · 36 citations · Full text

, , +16

The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid

K. Wilner, RA Hansen, C. Folger et al. · British Journal of Clinical Pharmacology · 2000 · 32 citations · Full text

, , +5

1–5 of 14